Unaudited Forward-Looking Statements Regarding Business Outlook
(In millions, except per share data) 

Business Outlook

Three Months Ending

December 30, 2023

GAAP

Measure

Non-GAAP

Adjustments**

Non-GAAP

Measure

Gross margin

53 %

0 %

53 %

Operating expenses

$123

$(29)

$94

Diluted earnings (loss) per share - low

$(2.39)

$0.73

$(1.66)

Diluted earnings (loss) per share - high

$(1.95)

$0.73

$(1.22)

Non-GAAP adjustments include the following estimates: stock compensation expense of $16.5 million,
intangible asset amortization of $6.2 million, termination costs of $6.5 million, and the associated tax impact from
the aforementioned items.  

Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)

September 30,

2023

December 31,

2022

Assets

Current assets:

   Cash and cash equivalents

$   159,928

$   499,915

   Short-term investments

257,157

692,024

   Accounts receivable, net

102,142

71,437

   Inventories

167,581

100,417

   Prepaid expenses and other current assets

86,727

97,570

Total current assets

773,535

1,461,363

Property and equipment, net

150,839

152,016

Goodwill

376,389

376,389

Other intangible assets, net

65,744

84,907

Other assets, net

108,555

94,753

Total assets

$1,475,062

$2,169,428

Liabilities and Stockholders' Equity

Current liabilities:

   Accounts payable

$     48,086

$     89,860

   Revolving line of credit

45,000

--

   Deferred revenue and returns liability

10,066

6,780

   Other current liabilities

61,991

89,136

Total current liabilities

165,143

185,776

Convertible debt, net

--

529,573

Other non-current liabilities

49,997

49,071

Total liabilities

215,140

764,420

Commitments and contingencies

Stockholders' equity:

   Preferred stock – $0.0001 par value; 10,000 shares authorized; no

      shares issued

--

--

   Common stock – $0.0001 par value; 250,000 shares authorized;  

      31,779 and 31,994 shares issued and outstanding at September
      30, 2023 and December 31, 2022, respectively

3

3

   Retained earnings

1,262,518

1,415,693

   Accumulated other comprehensive loss

(2,599)

(10,688)

Total stockholders' equity

1,259,922

1,405,008

Total liabilities and stockholders' equity

$1,475,062

$2,169,428